Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the emerging space economy, has announced an exciting new mission to the International Space Station (ISS) in collaboration with global biopharmaceutical giant Bristol Myers Squibb (BMS). The mission will utilize…
Nucleus RadioPharma announced the development of two new facilities, totaling over 100,000 square feet, in Mesa, Arizona, and Spring House, Pennsylvania. These state-of-the-art sites will integrate research, development, and commercial production under one roof, providing significant time and scale advantages…
NUCLIDIUM today announced the successful imaging of the first patient in a Phase 1 clinical trial evaluating its radiotracer candidate as a safe and effective diagnostic and disease-staging tool in prostate cancer patients. The candidate, 61Cu-NuriPro™ (61Cu-NODAGA-PSMA I&T), is part…
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect against serious infectious diseases, and its affiliate CyanVac LLC, today announced the presentation of…
Ferring Pharmaceuticals will present new research across four abstracts at the 2024 American Society for Reproductive Medicine (ASRM) Congress, taking place from October 19-23 in Denver, Colorado, and online. The abstracts include two oral and two poster presentations, reflecting Ferring’s…
Vertex Pharmaceuticals (Nasdaq: VRTX) announced that it will present Phase 3 data on suzetrigine, an investigational oral NaV1.8 pain signal inhibitor for moderate-to-severe acute pain, at the American Society of Anesthesiologists (ASA) annual meeting from October 18-22, 2024, in Philadelphia,…
Scholar Rock Grants Inducement Equity Awards to New Employees Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company dedicated to developing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, and other serious diseases influenced by protein growth factors, has announced the…
The “Powering Milwaukee Forward” initiative is set to enhance access to essential services and maternal healthcare in vulnerable communities across Milwaukee. Launched by GE HealthCare (Nasdaq: GEHC), the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation (CAFF), this philanthropic…
Ferring Pharmaceuticals Showcases Commitment to Advancing Fertility Care at 2024 ASRM Congress Ferring Pharmaceuticals will present new data from four abstracts at the 2024 American Society for Reproductive Medicine (ASRM) Congress, taking place from October 19-23 in Denver, Colorado, and…
Successful Cyclotron Irradiation of Ra-226 Paves the Way for Actineer’s Large-Scale Ac-225 Production for Cancer Treatments Actineer, the joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., has achieved a significant milestone by successfully producing Actinium-225 (Ac-225) through the…
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has announced that five of its abstracts have been accepted for e-Poster presentations at the 2024 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI), scheduled to be held in Boston,…
Nordic Pharma, a subsidiary of Nordic Group BV, is advancing the U.S. introduction of LACRIFILL® Canalicular Gel, a novel therapy for dry eye, during the 2024 American Academy of Ophthalmology (AAO) meeting. Following its U.S. launch in April, LACRIFILL will…
